http://purl.uniprot.org/citations/18286529 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
http://purl.uniprot.org/citations/18286529 | http://www.w3.org/2000/01/rdf-schema#comment | "BackgroundImprinted tumor suppressor genes may be particularly important in the pathogenesis of ovarian cancer. Two imprinted genes, paternally expressed 3 (PEG3) and aplasia Ras homologue member I (ARHI), are the most frequently down-regulated in ovarian cancers on gene expression arrays.MethodsPEG3 and ARHI expression levels were evaluated with real-time reverse-transcriptase polymerase chain reaction (PCR) analysis. Promoter methylation was measured by pyrosequencing, and loss of heterozygosity (LOH) was detected by PCR-LOH assays.ResultsPEG3 was down-regulated in 75% and ARHI was down-regulated in 88% of 40 ovarian cancers. ARHI CpG islands I and II were hypermethylated in 13 of 42 ovarian cancers (31%) and in 5 of 42 ovarian cancers (12%), respectively, and hypermethylation was associated with reduced ARHI expression in all 18 samples of ovarian cancer with CpG island hypermethylation. PEG3 was hypermethylated in 11 of 42 ovarian cancers (26%), and PEG3 expression was down-regulated in 10 of those 11 cancers. LOH was detected in 8 of 35 informative cases for ARHI (23%) and in 5 of 25 informative cases for PEG3 (20%). PEG3 and ARHI expression was highly correlated in human ovarian cancers (correlation coefficient [R]=0.69; P< .0001). PEG3 and ARHI also were methylated concordantly in ovarian cancers (R=0.36; P= .019). Re-expression of PEG3, similar to that of ARHI, markedly inhibited ovarian cancer growth. ARHI and PEG3 expression could be restored by treatment with 5-aza-2'-deoxycytidine and trichostatin A, consistent with the importance of promoter methylation and histone acetylation in regulating expression of both genes.ConclusionsLoss of expression of the growth-inhibitory imprinted genes ARHI and PEG3 through promoter methylation, LOH, and other mechanisms may stimulate clonogenic growth and contribute to the pathogenesis of a majority of ovarian cancers."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.org/dc/terms/identifier | "doi:10.1002/cncr.23323"xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Liu J."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Lu Z."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Yu Y."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Feng W."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Lu K.H."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Bast R.C. Jr."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Issa J.P."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Fishman D.M."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/author | "Marquez R.T."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/date | "2008"xsd:gYear |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/name | "Cancer"xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/pages | "1489-1502"xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/title | "Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation."xsd:string |
http://purl.uniprot.org/citations/18286529 | http://purl.uniprot.org/core/volume | "112"xsd:string |
http://purl.uniprot.org/citations/18286529 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/18286529 |
http://purl.uniprot.org/citations/18286529 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/18286529 |
http://purl.uniprot.org/uniprot/#_O95661-mappedCitation-18286529 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/18286529 |
http://purl.uniprot.org/uniprot/O95661 | http://purl.uniprot.org/core/mappedCitation | http://purl.uniprot.org/citations/18286529 |